HHS and 19 other government agencies can follow through with firing thousands of probationary workers after a federal appeals ...

The nonprofit drug pricing watchdog Institute for Clinical and Economic Review on Wednesday released a new report outlining ...

It’s a biotech environment without many good choices. Even before President Donald Trump’s tariff announcement pushed stock ...

FDA removes safety program requirement for Idorsia's blood pressure drug Tryvio, Solu gets $41M Series A with Eli Lilly backing, Vincerx shutters, Cytora reports stem cell win in ulcers ...

Novo Nordisk invests $1.05B in Brazil factory to boost GLP-1 drug production, including Wegovy and Ozempic, creating 600 jobs ...

Cartesian Therapeutics reports sustained benefits of Descartes-08 CAR-T therapy in generalized myasthenia gravis patients, ...

Executives of major pharmaceutical companies warned the European Union that they’re likely to take the US’ side amid the threat of new tariffs.

The state of the US biosimilar market isn't as healthy as it should be despite significant advances in the past decade, ...

The Trump administration on Tuesday said it will challenge a federal judge’s order that blocks its planned 15% rate limit on ...

FDA staff cuts could trigger user fee clawback mechanism, but experts including Patrick Frey and David Risinger say immediate ...

Novo Nordisk focused on a unique argument in federal appeals court on Tuesday in a case that will consider the extent to ...

The Trump administration will hike payments to Medicare Advantage insurers by more than $25 billion next year, according to ...